08/14/2025 7:30 AM | GENERAL ATLANTIC, L.P. (Filed by) Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
08/13/2025 11:49 AM | Capital International Investors (Filed by) Royalty Pharma (Subject)
| Form SCHEDULE 13G | |
08/08/2025 3:58 PM | Coyne Terrance P. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2025 4:00 PM | Legorreta Pablo G. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2025 3:52 PM | Royalty Pharma (Issuer) Urist Marshall (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2025 8:30 AM | Royalty Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025 6:10 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2025 10:56 AM | MORGAN STANLEY (Filed by) Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
07/31/2025 7:42 PM | Ho Carole (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2025 7:45 PM | Royalty Pharma (Issuer) WEATHERMAN ELIZABETH H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2025 3:23 PM | Royalty Pharma (Issuer) WEATHERMAN ELIZABETH H (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for RPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Royalty Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
07/17/2025 7:40 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2025 4:06 PM | Fernandez Henry A (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2025 4:05 PM | Legorreta Pablo G. (Filed by) Royalty Pharma (Subject)
| Form SCHEDULE 13D | |
05/20/2025 3:49 PM | Legorreta Pablo G. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2025 3:51 PM | Lloyd George W. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2025 3:52 PM | Coyne Terrance P. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2025 4:22 PM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2025 4:41 PM | Engelbert Catherine M. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:04 PM | Bassler Bonnie L (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:06 PM | Coric Vlad (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:07 PM | DESOUZA ERROL B (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:08 PM | Fernandez Henry A (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:09 PM | HODGSON DAVID C (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:11 PM | LOVE TED W (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 4:12 PM | Norden Gregory (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2025 9:39 AM | Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/09/2025 4:07 PM | Royalty Pharma (Issuer) Urist Marshall (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:10 PM | Coyne Terrance P. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:14 PM | Hite Christopher (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:15 PM | Lloyd George W. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:18 PM | Legorreta Pablo G. (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2025 8:14 AM | Royalty Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025 6:31 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2025 5:19 PM | Royalty Pharma (Subject) Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
04/21/2025 4:43 PM | Coric Vlad (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2025 4:40 PM | Coric Vlad (Reporting) Royalty Pharma (Issuer)
| Form 3/A | |
04/21/2025 4:18 PM | Royalty Pharma (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/11/2025 8:15 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/11/2025 7:45 AM | Royalty Pharma (Filer)
| Form DEFM14A | |
04/11/2025 7:50 AM | Royalty Pharma (Filer)
| Form ARS | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
04/11/2025 7:53 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2025 3:17 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/10/2025 3:06 PM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2025 4:45 PM | Fernandez Henry A (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 4:46 PM | Bassler Bonnie L (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2025 4:25 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
02/21/2025 3:30 PM | Royalty Pharma (Subject) Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
02/13/2025 5:03 AM | Royalty Pharma (Filer)
| Form PREM14A | |
02/12/2025 8:30 AM | FMR LLC (Filed by) Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025 6:38 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/17/2025 4:12 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/16/2025 4:15 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/15/2025 4:04 PM | Royalty Pharma (Subject)
| Form 425 | |
01/13/2025 7:40 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/13/2025 7:42 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025 4:21 PM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 4:26 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025 6:47 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/31/2024 3:05 PM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 2:15 PM | MORGAN STANLEY (Filed by) Royalty Pharma (Subject)
| Form SC 13G/A | |
11/06/2024 8:24 AM | Royalty Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 6:35 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 4:07 PM | Fernandez Henry A (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 4:08 PM | Bassler Bonnie L (Reporting) Royalty Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 7:39 AM | Royalty Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |